Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Rapaport

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1993
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patientsM H Rapaport, O Wolkowitz, J R Kelsoe, et al.
Journal of Clinical Psychopharmacology|June 1, 1996
A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disordersM H Rapaport, S Zisook, T Frevert, et al.
Journal of Affective Disorders|May 18, 2000
Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivationC Clark, R Dupont, S Golshan, et al.
American Journal of Medical Genetics|July 14, 1999
Analysis of GNAZ gene polymorphism in bipolar affective disorderT Saito, D F Papolos, D Chernak, et al.
Anxiety|January 1, 1996
Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety disordersM H Rapaport, T Frevert, S Babior, et al.
Schizophrenia Research|May 24, 1997
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteersM H Rapaport, C G McAllister, D Pickar, et al.
Psychopharmacology Bulletin|January 1, 1989
Smooth pursuit eye movements in schizophrenia: effects of neuroleptic treatment and caffeineR E Litman, D W Hommer, T Clem, et al.
Biological Psychiatry|July 1, 1998
Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controlsE Seifritz, J C Gillin, M H Rapaport, et al.
The Journal of Clinical Psychiatry|February 1, 1995
Gender differences in outpatient research subjects with affective disorders: a comparison of descriptive variablesM H Rapaport, P M Thompson, J R Kelsoe, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twinsM H Rapaport, E F Torrey, C G McAllister, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1993
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patientsM H Rapaport, O Wolkowitz, J R Kelsoe, et al.
Journal of Clinical Psychopharmacology|June 1, 1996
A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disordersM H Rapaport, S Zisook, T Frevert, et al.
Journal of Affective Disorders|May 18, 2000
Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivationC Clark, R Dupont, S Golshan, et al.
American Journal of Medical Genetics|July 14, 1999
Analysis of GNAZ gene polymorphism in bipolar affective disorderT Saito, D F Papolos, D Chernak, et al.
Anxiety|January 1, 1996
Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety disordersM H Rapaport, T Frevert, S Babior, et al.
Schizophrenia Research|May 24, 1997
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteersM H Rapaport, C G McAllister, D Pickar, et al.
Psychopharmacology Bulletin|January 1, 1989
Smooth pursuit eye movements in schizophrenia: effects of neuroleptic treatment and caffeineR E Litman, D W Hommer, T Clem, et al.
Biological Psychiatry|July 1, 1998
Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controlsE Seifritz, J C Gillin, M H Rapaport, et al.
The Journal of Clinical Psychiatry|February 1, 1995
Gender differences in outpatient research subjects with affective disorders: a comparison of descriptive variablesM H Rapaport, P M Thompson, J R Kelsoe, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twinsM H Rapaport, E F Torrey, C G McAllister, et al.
Pageof 9